Ruth R. Faden, Liza Dawson, Alison S. Bateman-House, Dawn Mueller Agnew, Hilary Bok, Dan W. Brock, Aravinda Chakravarti, Xiao-Jiang Gao, Mark Greene, John A. Hansen, Patricia A. King, Stephen J. O.’Brien & David H. Sachs
Hastings Center Report 33 (6):13-27 (2003)
|Abstract||If stem cell-based therapies are developed, we will likely confront a difficult problem of justice: for biological reasons alone, the new therapies might benefit only a limited range of patients. In fact, they might benefit primarily white Americans, thereby exacerbating long-standing differences in health and health care.|
|Keywords||stem cell bioethics Medical JUSTICE RACE|
|Categories||categorize this paper)|
|Through your library||Configure|
Similar books and articles
Liza Dawson, Alison S. Bateman-House, Dawn Mueller Agnew, Hilary Bok, Dan W. Brock, Aravinda Chakravarti, Mark Greene, Patricia King, Stephen J. O'Brien, David H. Sachs, Kathryn E. Schill, Andrew Siegel & Davor Solter (2003). Safety Issues In Cell-Based Intervention Trials. Fertility and Sterility 80 (5):1077-1085.
Mark Greene (2006). To Restore Faith and Trust: Justice and Biological Access to Cellular Therapies. Hastings Center Report 36 (1):57-63.
Nikolaus Knoepffler (2004). Stem Cell Research: An Ethical Evaluation of Policy Options. Kennedy Institute of Ethics Journal 14 (1):55-74.
Tamra Lysaght & Alastair V. Campbell (2013). Broadening the Scope of Debates Around Stem Cell Research. Bioethics 27 (5):251-256.
Aaron D. Levine & Leslie E. Wolf (2012). The Roles and Responsibilities of Physicians in Patients' Decisions About Unproven Stem Cell Therapies. Journal of Law, Medicine and Ethics 40 (1):122-134.
Mark T. Brown (2009). Moral Complicity in Induced Pluripotent Stem Cell Research. Kennedy Institute of Ethics Journal 19 (1):pp. 1-22.
David Magnus (2010). Translating Stem Cell Research: Challenges at the Research Frontier. Journal of Law, Medicine and Ethics 38 (2):267-276.
Insoo Hyun (2010). Allowing Innovative Stem Cell-Based Therapies Outside of Clinical Trials: Ethical and Policy Challenges. Journal of Law, Medicine and Ethics 38 (2):277-285.
Mark S. Moller (2008). Human Embryonic Stem Cell Research, Justice, and the Problem of Unequal Biological Access. Philosophy, Ethics, and Humanities in Medicine 3 (1):22.
P. Patel (2006). A Natural Stem Cell Therapy? How Novel Findings and Biotechnology Clarify the Ethics of Stem Cell Research. Journal of Medical Ethics 32 (4):235-239.
Glenn McGee & Arthur L. Caplan (1999). The Ethics and Politics of Small Sacrifices in Stem Cell Research. Kennedy Institute of Ethics Journal 9 (2):151-158.
Ronald K. F. Fung & Ian H. Kerridge (2013). Uncertain Translation, Uncertain Benefit and Uncertain Risk: Ethical Challenges Facing First-in-Human Trials of Induced Pluripotent Stem (Ips) Cells. Bioethics 27 (2):89-96.
David A. Jensen (2008). Abortion, Embryonic Stem Cell Research, and Waste. Theoretical Medicine and Bioethics 29 (1):27-41.
Bernard Dickens, International Society for Stem Cell Research (ISSCR) Guidelines for the Conduct of Human Embryonic Stem Cell Research (December 2006).
Rebecca Dresser (2010). Stem Cell Research as Innovation: Expanding the Ethical and Policy Conversation. Journal of Law, Medicine and Ethics 38 (2):332-341.
Added to index2011-10-24
Total downloads5 ( #169,891 of 722,765 )
Recent downloads (6 months)1 ( #60,247 of 722,765 )
How can I increase my downloads?